http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1508150-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a431d489d181a29572380553d1aa97 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 1986-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1989-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf490e0b6317e974ff680f144bcc32d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53437ef7952eabe90d21f97dcb17a987 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26fc1efa7884ba9bd125dfa33c0170e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c4926fa7a449fe49d3f91209b5d17e4 |
| publicationDate | 1989-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1508150-A1 |
| titleOfInvention | Method of determining the content of precallicrein in blood plasma |
| abstract | This invention relates to medical biochemistry, and specifically to methods for determining the content of prekallicrein in the blood plasma. The purpose of the invention is to increase the sensitivity of the method of determination due to the specific binding of the free inhibitor of kallikrein - α 2 - macroglobulin. To do this, in a known method, prior to activation with kaolin, methylamine is added to the plasma at a final concentration of 1-1.2%, kept for 1.5-2 hours at room temperature. 1 tab. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19701405-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19701405-C2 |
| priorityDate | 1986-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.